Planned sale

Disc Medicine (IRON): Officer filed to sell ~$1.3M

WILLIAM SAVAGE, Officer at Disc Medicine, filed to sell ~$1.3M of Disc Medicine shares.

~$1.3M
planned to sell · 16K shares, around Nov 10, 2026
Planned for
Nov 10, 2026
Notice filed
Nov 10, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 19, 2026Company filing · Form 8-K · Material agreement, ResultsSigned an important agreement, and reported its results (and 1 more item)
  2. Oct 19, 2026Insider · 1 personInsiders: 3 sales (~$879K)
  3. Oct 20, 2026Insider · 1 personInsiders: 3 sales (~$425K)
  4. Oct 21, 2026Insider · 1 personInsiders: 3 sales (~$2.0M)
  5. Oct 26, 20265% stakeAI DMI LLC filed an activist stake (13D) of 6.6%
  6. Nov 5, 2026Company filing · Form 8-K · ResultsReported its results
  7. Nov 10, 2026Insider · Their largest sale since 2023Officer sold ~$1.36M of IRON shares in the open market
View the official recordSEC Form 144

How to read SEC Form 144

Form 144 is a notice that a company insider plans to sell shares. It is filed when the sell order is placed, so it announces a planned sale and does not prove that the sale took place.

Full guide: What is an SEC Form 144?

What else is on file for Disc Medicine

For Disc Medicine, OQRO holds 23 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its IRON page.

How this filing works

Explore the data

Other disclosures at Disc Medicine

Everything OQRO holds on this company is on its IRON page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data